Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Binquet
C
C
Saillour
F
F
Bernard
N
N
Marimoutou
C
C
Dabis
F
F
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000401:mortality*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy* / Q000401:mortality*; D004359:Drug Therapy, Combination; D005260:Female; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011379:Prognosis; D016019:Survival Analysis
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors